Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: Assessment of 987 Hospitals

Ryan P. Merkow*, Karl Y. Bilimoria, Martin D. McCarter, Warren B. Chow, Clifford Y. Ko, David J. Bentrem

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'Use of multimodality neoadjuvant therapy for esophageal cancer in the United States: Assessment of 987 Hospitals'. Together they form a unique fingerprint.

INIS

Medicine and Dentistry